Cardiotoxicity of Cancer Therapy
Authors:
- 1 January 1999
- journal article
- research article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 17 (6) , 408-422
Abstract
(1999). Cardiotoxicity of Cancer Therapy. Cancer Investigation: Vol. 17, No. 6, pp. 408-422.Keywords
This publication has 116 references indexed in Scilit:
- Clinical Cardiotoxicity of 5‐FluorouracilThe Journal of Clinical Pharmacology, 1993
- Cardioprotection by ICRF187 against high dose anthracycline toxicity in children with malignant disease.Heart, 1993
- Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast CancerNew England Journal of Medicine, 1988
- Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapyThe American Journal of Medicine, 1987
- Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicityAmerican Heart Journal, 1983
- Late Cardiac Effects of Therapeutic Mediastinal IrradiationNew England Journal of Medicine, 1983
- Case 44-1981New England Journal of Medicine, 1981
- Dose-effect and structure-function relationships in doxorubicin cardiomyopathyAmerican Heart Journal, 1981
- Revised standards for triceps and subscapular skinfolds in British children.Archives of Disease in Childhood, 1975
- Subacute Effusive-Constrictive PericarditisCirculation, 1971